Viking Therapeutics (VKTX) News Today → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free VKTX Stock Alerts $76.23 +0.81 (+1.07%) (As of 12:16 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineViking Therapeutics (NASDAQ:VKTX) Shares Up 0.6%marketbeat.com - April 29 at 3:18 PMQ4 2024 Earnings Forecast for Viking Therapeutics, Inc. (NASDAQ:VKTX) Issued By Leerink Partnrsamericanbankingnews.com - April 29 at 4:02 AMQ2 2024 Earnings Estimate for Viking Therapeutics, Inc. Issued By HC Wainwright (NASDAQ:VKTX)americanbankingnews.com - April 29 at 1:40 AMViking Therapeutics, Inc. to Post Q2 2024 Earnings of ($0.17) Per Share, William Blair Forecasts (NASDAQ:VKTX)americanbankingnews.com - April 29 at 1:40 AMIs Viking Therapeutics Incredibly Undervalued?fool.com - April 28 at 10:30 AMCan This High-Flying Stock 10x in 10 Years?fool.com - April 28 at 9:07 AMViking Therapeutics (NASDAQ:VKTX) Shares Down 0.3% americanbankingnews.com - April 28 at 3:58 AMHC Wainwright Reiterates Buy Rating for Viking Therapeutics (NASDAQ:VKTX)americanbankingnews.com - April 27 at 3:24 AMViking Therapeutics (NASDAQ:VKTX) Trading Down 0.3%marketbeat.com - April 26 at 6:32 PMViking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEOmsn.com - April 26 at 8:33 AMBuy Rating Affirmed for Viking Therapeutics Amidst Strong Clinical Progress and Strategic Movesmarkets.businessinsider.com - April 26 at 8:33 AMViking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - April 26 at 8:33 AMViking Therapeutics (NASDAQ:VKTX) Trading Up 1.6% After Strong Earningsamericanbankingnews.com - April 26 at 1:36 AMViking Therapeutics (NASDAQ:VKTX) Stock Price Up 1.6% on Strong Earningsmarketbeat.com - April 25 at 12:06 PMViking Therapeutics (NASDAQ:VKTX) Announces Earnings Resultsmarketbeat.com - April 25 at 11:05 AMViking Therapeutics (NASDAQ:VKTX) Given Buy Rating at HC Wainwrightmarketbeat.com - April 25 at 8:09 AMViking Therapeutics (NASDAQ:VKTX) Stock Rating Upgraded by StockNews.comamericanbankingnews.com - April 25 at 2:21 AMVKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024investorplace.com - April 24 at 11:13 PMViking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updatefinance.yahoo.com - April 24 at 4:29 PMViking Therapeutics (NASDAQ:VKTX) Stock Price Up 1.8%marketbeat.com - April 24 at 4:22 PM3 Biotech Stocks With Skyrocketing Potential: April 2024investorplace.com - April 24 at 11:36 AM3 Red-Hot Biotech Rockets Blasting Off in 2024investorplace.com - April 24 at 8:00 AMViking Therapeutics (NASDAQ:VKTX) Shares Up 4.6%marketbeat.com - April 23 at 2:58 PMBetter Buy: Pfizer vs. Viking Therapeuticsfool.com - April 23 at 9:15 AM3 Stocks With the Potential to Surpass Analyst Expectations for 2024msn.com - April 23 at 7:44 AMViking Therapeutics (NASDAQ:VKTX) Shares Down 0.7% marketbeat.com - April 22 at 2:32 PMViking Therapeutics, Inc. (NASDAQ:VKTX) Shares Purchased by Knights of Columbus Asset Advisors LLCmarketbeat.com - April 22 at 6:24 AMWegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?marketbeat.com - April 22 at 6:05 AMWegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs? (VKTX)marketbeat.com - April 22 at 6:05 AMViking Therapeutics (VKTX) to Release Quarterly Earnings on Wednesdayamericanbankingnews.com - April 22 at 5:10 AMViking Therapeutics (NASDAQ:VKTX) Stock Price Down 2.2%americanbankingnews.com - April 21 at 3:56 AMViking Therapeutics (NASDAQ:VKTX) Shares Down 2.2% marketbeat.com - April 19 at 12:45 PMViking Therapeutics (NASDAQ:VKTX) Stock Price Down 2%marketbeat.com - April 18 at 2:47 PMViking Therapeutics (NASDAQ:VKTX) Stock Price Down 0%marketbeat.com - April 17 at 12:42 PMLLY, VKTX, or NVO: Which Weight-Loss Drugmaker Could Gain the Best Returns?msn.com - April 17 at 3:24 AMViking Therapeutics (NASDAQ:VKTX) Trading Up 1.9%marketbeat.com - April 16 at 1:40 PMThese 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?investorplace.com - April 16 at 1:19 PMRaymond James & Associates Grows Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX)marketbeat.com - April 16 at 4:08 AMViking Therapeutics (NASDAQ:VKTX) Shares Down 0.4% marketbeat.com - April 15 at 3:57 PMInternational Assets Investment Management LLC Buys 349,186 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX)marketbeat.com - April 15 at 4:44 AM3 Magnificent Stocks That Could Double or More by 2030fool.com - April 13 at 8:47 AMViking Therapeutics (NASDAQ:VKTX) Trading Down 2.2%marketbeat.com - April 12 at 2:30 PMShed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027investorplace.com - April 12 at 6:25 AMViking Therapeutics (NASDAQ:VKTX) Stock Price Down 1.1%marketbeat.com - April 11 at 2:29 PMIf You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Namesinvestorplace.com - April 11 at 1:49 PMViking Therapeutics (NASDAQ:VKTX) Stock Price Down 3%marketbeat.com - April 10 at 1:39 PMViking Therapeutics's Options: A Look at What the Big Money is Thinkingbenzinga.com - April 9 at 3:18 PMViking Therapeutics (NASDAQ:VKTX) Stock Price Down 3.6%marketbeat.com - April 9 at 12:33 PMBetter Buy: CRISPR Therapeutics Vs. Viking Therapeuticsfool.com - April 9 at 10:18 AMBetter Buy: CRISPR Therapeutics Vs. Viking Therapeuticsfool.com - April 9 at 10:00 AM Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address the harsh reality of the stock market (Ad)OK, you’re not supposed to say this In fact, maverick investor Graham Lindman says it’s become the silent elephant in the room that everyone is pretending isn’t there. But he just said it: Most stocks suck. And he isn’t saying that figuratively or subjectively… You see, 96% of stocks underperform. Just 4% of “Apex Stocks” generate virtually all the wealth. All you have to do is watch here for all the details. VKTX Media Mentions By Week VKTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼0.810.34▲Average Medical News Sentiment VKTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼317▲VKTX Articles Average Week Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Intra-Cellular Therapies News Today Jazz Pharmaceuticals News Today Cytokinetics News Today Cerevel Therapeutics News Today Elanco Animal Health News Today Ionis Pharmaceuticals News Today Ascendis Pharma A/S News Today Apellis Pharmaceuticals News Today Legend Biotech News Today Blueprint Medicines News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
